These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Tackling insulin resistance. Control of etiology in type 2 diabetes]. MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300 [No Abstract] [Full Text] [Related]
3. [Differential therapy with oral antidiabetic drugs]. Sachse G Z Gesamte Inn Med; 1993 Mar; 48(3):127-9. PubMed ID: 8475635 [TBL] [Abstract][Full Text] [Related]
4. [Insulin analogs and new antidiabetic agents. Prospects in diabetes therapy]. Gallwitz B; Schmidt WE Internist (Berl); 1997 Jun; 38(6):617-24; discussion 624. PubMed ID: 9265011 [No Abstract] [Full Text] [Related]
5. Intensive insulin for type 2 diabetes: the risk of causing harm. Nolan CJ; Ruderman NB; Prentki M Lancet Diabetes Endocrinol; 2013 Sep; 1(1):9-10. PubMed ID: 24622256 [No Abstract] [Full Text] [Related]
6. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Lebovitz HE Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic profile of oral antidiabetic agents]. Okubo M; Yamane K; Kohno N Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011 [No Abstract] [Full Text] [Related]
8. [Combination therapy of oral antidiabetic drugs with insulin]. Lotz N; Bachmann W Z Gesamte Inn Med; 1993 Mar; 48(3):130-4. PubMed ID: 8475636 [TBL] [Abstract][Full Text] [Related]
9. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?]. Lotz N MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870 [No Abstract] [Full Text] [Related]
10. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus. Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173 [TBL] [Abstract][Full Text] [Related]
11. The thiazolidinediones: a new class of antidiabetic agents. Barnett A Hosp Med; 2000 Mar; 61(3):185-8. PubMed ID: 10789389 [TBL] [Abstract][Full Text] [Related]
12. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes. Westphal SA; Palumbo PJ Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711 [No Abstract] [Full Text] [Related]
13. [Integrated drug therapy of the metabolic syndrome]. Julius U; Hanefeld M Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266 [No Abstract] [Full Text] [Related]
14. The UK Prospective Diabetes Study. Bailey CJ; Grant PJ Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806 [No Abstract] [Full Text] [Related]
15. The UK Prospective Diabetes Study. Evans M Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807 [No Abstract] [Full Text] [Related]
16. The UK Prospective Diabetes Study. Kerner W Lancet; 1998 Dec; 352(9144):1934. PubMed ID: 9863811 [No Abstract] [Full Text] [Related]
17. [The sulfanilamide resistance of patients with type-2 diabetes mellitus]. Gendeleka GF; Lakiza VV Lik Sprava; 1993 Apr; (4):51-6. PubMed ID: 8209448 [No Abstract] [Full Text] [Related]
18. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides]. Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877 [No Abstract] [Full Text] [Related]
19. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus]. Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243 [TBL] [Abstract][Full Text] [Related]
20. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence. McFarland MS; Knight TN; Brown A; Thomas J South Med J; 2010 Jan; 103(1):58-65. PubMed ID: 19996858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]